Diana Mandelker

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Multimodal predictors of recurrence in patients with germline BRCA1/2-associated ovarian cancer receiving frontline PARP inhibitor maintenance

  Gynecologic Oncology · 2026-04-23

• Cancer type-specific variation in patterns of driver alterations across 50,000 tumors

  Cancer Cell · 2026-04-18

• Cancer type-specific variation in patterns of driver alterations across 50,000 tumors

  Cancer Cell · 2026-03-26 · 2 citations

• Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the <scp> <i>RTEL1</i> R1264H </scp> Founder Variant

  American Journal of Medical Genetics Part A · 2025-12-22

• Supplemental Materials and Methods from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

  2025-12-17

• Supplemental Table 1, Supplemental Table 2, Supplemental Table 3, Supplemental Table 6, Supplemental Table 7, Supplemental Figure 1, and Supplemental Figure 2 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

  2025-12-17

• Supplemental Table 4 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

  2025-12-17

• Data from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

  2025-12-17

• Supplemental Table 5 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

  2025-12-17

• Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

  2025-11-26

• Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

  2025-11-26

• Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

  2025-11-26

• Supplementary Data from MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

  2025-11-25

• Supplementary Table S1 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma

  2025-11-25

• Supplementary Figure S1 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma

  2025-11-25

• Supplementary Table S3 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma

  2025-11-25

• Supplementary Figure S2 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma

  2025-11-25

• Supplementary Table S2 from The Impact of Germline Alterations in Appendiceal Adenocarcinoma

  2025-11-25

• Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum

  npj Precision Oncology · 2025-11-19 · 1 citations

• Spectrum, molecular features, and clinical outcomes of hematologic malignancies and clonal hematopoiesis in li fraumeni syndrome

  Blood · 2025-11-03 · 1 citations